SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Internet Computer is a decentralized cloud blockchain that pursues the $1+ trillion cloud market - hosting apps, websites and enterprise systems, fully onchain, where they benefit from extraordinary security and resilience, can do multi-chain token processing, and can be administered in a decentralized way for safety.  A core purpose is “self-writing cloud,” where AI creates apps for mass market users, which are sophisticated and secure, in response to instructions they provide over chat.  The ICP token is burned powering onchain apps, and is a cryptocurrency used in network governance staking.  It’s easy to try - use AI to create onchain apps (e.g. caffeine.ai) or use an online IDE to write serverless code yourself (e.g. icp.ninja)!

Internet Computer

Internet Computer (ICP) is trending as traders discuss a potential supply squeeze, noting low reserves on Coinbase and Binance accumulating ICP tokens. The community is actively debating the possibility of a price surge, with some advocating for buying spot rather than leveraged positions, while others believe it will reject resistance at $6.30 and head lower again.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors discuss the implications of an upcoming oral explanation (OE) with the CHMP for its Alzheimer's drug, Blarcamesine, which could influence the potential for EU approval. While some view the OE as a standard step, others express concern about outstanding issues and the possibility of a conditional approval. Community members are weighing the risk/reward, analyzing options data, and debating the potential impact on the stock depending on the outcome.

Leifras Co., Ltd. Engages in sport training, event and alliance & club activity support and healthcare activities. It provides services related to the organization and operations of sports schools and sports events for children and it also operate a robust social business sector, dispatching sports coaches to meet various community needs. The company was founded by Kiyotaka Ito on August 28, 2001 and is headquartered in Tokyo, Japan.

Leifras Co Ltd - ADR

LEIFRAS Co., Ltd. American Depositary Shares

LEIFRAS Co. is experiencing a surge in attention, with community members pointing to it as a potential multi-day runner. Discussions revolve around the stock's significant upward movement and whether it's a pump and dump scheme, with some comparing it to other recent IPOs. Traders are actively seeking the next stock to mirror LFS's performance, leading to the mention of related or sympathy plays.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending as traders discuss its potential as a buyout target following recent activity in the pharma sector, with community members highlighting its pipeline and comparing it to other companies. Speculation includes potential interest from both established pharmaceutical firms and non-traditional players, while some debate whether the company will pursue partnerships or remain independent. Short squeezes and analyst price targets are also being actively discussed.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as investors discuss the potential impact of a new government agreement on weight-loss drug pricing and coverage, with community members weighing whether the expanded access to patients will offset reduced prices. Some traders are speculating about upcoming catalysts, including potential FDA approval for an oral version of Wegovy and news from the OMER deal. The conversation also includes discussion around the company's strategic moves, including a bidding war with Pfizer for Metsera.

Advanced Micro Devices, Inc. engages in the provision of semiconductor businesses. It operates through the following segments: Data Center, Client, Gaming, and Embedded. The Data Center segment includes server-class CPUs, GPUs, AI accelerators, DPUs, FPGAs, SmartNICs, and Adaptive SoC products. The Client segment refers to the computing platforms, which are a collection of technologies that are designed to work together to provide a more complete computing solution. The Gaming segment is a fundamental component across many products and can be found in APU, GPU, SoC or a combination of a discrete GPU with another product working in tandem. The Embedded segment focuses on the embedded CPUs, GPUs, APUs, FPGAs, and Adaptive SoC products. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending amid strong AI chip demand and projections of significant annual revenue growth, with CEO Lisa Su's optimistic outlook fueling bullish sentiment. The community is actively discussing potential price target upgrades and AMD's ability to gain market share in the data center and AI spaces. Investor focus is on the company's financial analyst day and its implications for future growth.

Spell Token

Spell Token is trending as community members discuss potential catalysts and partnerships while eyeing possible breakouts. Bullish sentiment seems to be building, with some anticipating a run to higher price levels. Conversely, some traders express concern about dilution and the token's historical performance relative to Bitcoin.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as investors react to recent earnings, which revealed no revenue, sparking debates about its $16B market cap and future potential in the nuclear energy sector. Community discussions revolve around the company's valuation, regulatory hurdles, and upcoming catalysts, with some highlighting the potential for significant growth due to increased demand for clean energy and AI power, while others remain skeptical about its near-term prospects. Recent DOE approval news provides some optimism, although technical analysis suggests bearish signals for the stock.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company was founded on June 3, 2024 and is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Paramount Skydance is trending following its latest earnings report and strategic update, which included plans to raise Paramount+ prices and a focus on streaming profitability. Community discussions revolve around the company's growth initiatives, potential workforce reductions, and increased cost-saving targets. Some investors are speculating about a potential acquisition of Warner Bros. Discovery.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

Fueled by anticipation for upcoming presentations at the AASLD Liver Meeting in November, GALT is trending as the community discusses the potential of Belapectin, especially in combination with GLP-1 drugs. Speculation around a potential short squeeze due to high short interest and potential partnerships or a buyout before year-end are adding to the current buzz. The community is actively debating potential buyout prices and the impact of upcoming presentations on the stock's valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$GHC likely outcome if top 4 rule is lifted

$GHC shopping around broadcasting would be the contrarian bet. Market multiple would contract. However, very attractive cash IRR because assumed pension liabilities, SIPs, and VRIP can be covered by Buffett/KMG’s pension surplus. Wouldn’t be bothered to see some moves there